Leigh Zawel, See Remarks at Cullinan Oncology, Inc. (CGEM), sold 1,079 shares at $25.00 ($27K) on 2021-10-07, disclosed to the SEC on 2021-10-12.
Scheduled sale ($27k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CGEM | SELL | 2021-09-08 | $1.6M | — | Filing → |
| CGEM | SELL | 2021-08-26 | $815K | — | Filing → |
| CGEM | SELL | 2021-08-26 | $1.4M | — | Filing → |